Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis Isolates from the northern region of South Africa

Journal of Clinical Microbiology

Volumn 50, Issue 9, 2012, Pages 2857-2862

  Said, Halima M ^a   Kock, Marleen M ^a,b   Ismail, Nazir A ^a,b   Mphahlele, Matsie ^c   Baba, Kamaldeen ^a,b   Omar, Shaheed V ^a   Osman, Ayman G ^a   Hoosen, Anwar A ^a,b   Ehlers, Marthie M ^a,b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DISEASE TRANSMISSION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; POPULATION STRUCTURE; PRIORITY JOURNAL; SOUTH AFRICA; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CAPREOMYCIN; CHILD; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; KANAMYCIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84865165337     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00358-12     Document Type: Article

References (33)

1. Barlow RE, et al. 2001. Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:2453-2457. (Pubitemid 32606218)
2. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. 2002. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10:45-52. (Pubitemid 34075264)
3. Brudey K, et al. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the Fourth International Spoligotyping Database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6:23. doi:10.1186/1471-2180-6-23.
4. Centers for Disease Control and Prevention. 3 November 2006, posting date. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 55:1176. www.cdc.gov/mmwr/preview/ mmwrhtml/mm5543a4.htm.
5. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55:301-305.
6. Centers for Disease Control and Prevention. 2007. Extensively drugresistant tuberculosis - United States, 1993-2006.MMWRMorb. Mortal. Wkly. Rep. 56:250-253.
7. Chihota VN, et al. 2012. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J. Clin. Microbiol. 50:995-1002.
8. Cowan LS, Mosher L, Diem L, Massey JP, Crawford JT. 2002. Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. J. Clin. Microbiol. 40:1592-1602. (Pubitemid 34493125)
9. Filliol I, et al. 2002. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347-1349. (Pubitemid 35334712)
10. Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849.
11. Johnson R, et al. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung. Dis. 14:119-121.
12. Kamerbeek J, et al. 1997. Simultaneous detection and strain differentiation of M. tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914. (Pubitemid 27146535)
13. Koornhof H, Ihekweazu C, Erasmus L, Coetzee G. 2011. Update on Corporate Data Warehouse-derived MDR- and XDR-TB statistics for eight provinces in South Africa, January 2007 to 30th June 2011. Commun. Dis. Surveill. Bull. 9(3):68-72. www.nicd.ac.za/assets/files/Bulletin%20August%202011(3).pdf.
14. Le Flèche P, Fabre M, Denoeud F, Koeck JL, Vergnaud G. 2002. High resolution, on-line identification of strains from the Mycobacterium tuberculosis complex based on tandem repeat typing. BMC Microbiol. 2:37. doi:10.1186/1471-2180-2-37.
15. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. 2006. Molecular epidemiology of tuberculosis: current insights. Clin. Microbiol. Rev. 19:658-685. (Pubitemid 44582976)
16. Mazars E, et al. 2001. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc. Natl. Acad. Sci. U. S. A. 98:1901-1906. (Pubitemid 32165595)
17. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes, vol. 23. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. National Health Laboratory Services. 2010. National Institute for Communicable Diseases annual report 2009. http://www.nicd.ac.za/assets/files/ Annual-report-2009.pdf.
19. Small PM, et al. 1994. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-1709.
20. Sola C, et al. 2003. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect. Genet. Evol. 3:125-133. (Pubitemid 36686755)
21. Stavrum R, et al. 2009. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J. Clin. Microbiol. 47:1848-1856.
22. Streicher EM, et al. 2004. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 42:891-894.
23. Supply P, Magdalena J, Himpens S, Locht C. 1997. Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol. Microbiol. 26:991-1003. (Pubitemid 27507883)
24. Supply P, et al. 2000. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol. Microbiol. 36:762-771. (Pubitemid 30258858)
25. Supply P, et al. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 39:3563-3571. (Pubitemid 32954502)
26. Supply P, et al. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510. (Pubitemid 44937085)
27. van Embden JD, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
28. van Soolingen D, et al. 1999. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J. Infect. Dis. 180:726-736.
29. Van Soolingen D. 2001. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J. Intern. Med. 249:1-26. (Pubitemid 32147089)
30. Warren R, et al. 1999. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 20:1807-1812. (Pubitemid 29320479)
31. World Health Organization. 2008. Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global-report/en/.
32. World Health Organization. 2010. Multidrug and extensively drugresistant TB (M/XDR-TB) 2010 global report on surveillance and response. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf.
33. World Health Organization. 2010. Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global-report/en/.